Table 3: Laboratory parameters of non-severe COVID-19 patients with or without hepatitis virus infection.

Variable (unit)

Total

(n = 200)

With hepatitis virus infection (n = 37)

without hepatitis virus infection (n = 163)

P value

Platelets (109/L)

207.5(176.0~256.25)

205.0(168.0~246.5)

209.0(180.0~262.0)

0.288

Lymphocytes (109/L)

1.49(1.21~1.84)

1.39(1.13~1.87)

1.50(1.22~1.84)

0.308

CD3+ T cells (count/uL)

1198.0(941.5~1571.0)

1036.0(715.0~1590.5)

1228.5(1015.0~1562.8)

0.048

CD3+CD4+ T cells (count/uL)

710.0(533.5~924.0)

655.0(411.5~855.5)

741.0(589.8~930.0)

0.045

CD3+CD8+ T cells (count/uL)

430.0(323.5~594.0)

421.0(290.5~509.5)

443.5(338.3~599.5)

0.181

CD19+ B cells (count/uL)

218.0(116.5~304.5)

198.0(97.0~271.0)

234.5(124.5~322.8)

0.131

PT (s)

11.6(11.1~12.2)

11.9(11.5~12.3)

11.5(11.1~12.2)

0.032

PT-INR

1.06(1.02~1.12)

1.09(1.06~1.13)

1.06(1.02~1.12)

0.029

CRP (mg/L)

2.25(1.2~5.3)

2.6(1.2~7.55)

2.1(1.2~4.9)

0.369

PCT (0~15 mm/h)

0.05(0.05~0.05)

0.05(0.05~0.06)

0.05(0.05~0.05)

0.021

LDH (U/L)

163.0(142.0~190.0)

163.0(143.5~193.5)

163.5(141.75~190.25)

0.829

NLR

2.05(1.59~2.74)

2.0(1.65~2.57)

2.06(1.59~2.74)

0.892

ALT (U/L)

26.0(16.25~43)

30.0(19.5~42.0)

26.0(16.0~43.0)

0.368

AST (U/L)

22.0(17.0~29.0)

26.0(19.0~104.0)

21.0(17.0~29.0)

0.156

DBIL (umol/L)

2.0(1.53~2.7)

2.3(1.65~3.2)

2.0(1.5~2.6)

0.097

CKMB (U/L)

9.0(7.0~13.0)

9.0(7.0~15.0)

9.0(7.0~12.0)

0.230

IL-6 (ng/mL)

2.08(0.42~4.6)

3.1(0.86~7.29)

1.89(0.42~4.39)

0.272

IL-10 (ng/mL)

1.42(0.81~3.88)

2.36(1.17~7.21)

1.34(0.75~2.77)

0.079

Abbreviation: COVID-19: Coronavirus Disease 2019; IQR: Interquartile Range; PT: Prothrombin Time; PT-INR: International Normalized Ratio of Prothrombin Time; CRP: C-Reactive Protein; PCT: Procalcitonin; LDH: Lactate Dehydrogenase; NLR: Neutrophil to Lymphocyte Ratio; DBIL: Direct Bilirubin; AST: Aspartate Aminotransferase; ALT: Alanine Amino Transferase; CK: Creatine Kinase; IL: Interleukin.